Transcription of REPORT - Biotechnology by Amgen
{{id}} {{{paragraph}}}
Example: confidence
REPORT - Biotechnology by Amgen
BIOSIMILARS TRENDS IN2 015 REPORT2 MESSAGE FROM AmgenMESSAGE FROM EDITORIAL COUNCILINTRODUCTION & EXECUTIVE SUMMARYPAYER PERCEPTIONS OF BIOSIMILARSPAYER READINESS FOR BIOSIMILARSPAYER EXPECTATIONS OF PRICE & ACCESS AS CENTRAL VALUE DRIVERS FOR BIOSIMILARSLOOKING AHEADGLOSSARY4581220364648 TABLE OF CONTENTS3 WHAT ARE BIOLOGICS AND BIOSIMILARS? A biologic medicine is a large molecule derived from living cells that is used to treat or prevent disease, such as a therapeutic protein, DNA vaccine, monoclonal antibody ( , MAB) or fusion These medicines are far more complex than small molecule drugs and are highly sensitive, making them more difficult to characterize and As more is learned about the biological mechanisms of diseases, new biologic medicines can be developed that target the causes of disease, potentially altering the course of disease rather than treating Biosimilars are biological medicines that are considered highly similar to the originator (the reference product).
6. THE 2015 TRENDS IN BIOSIMILARS REPORT . The . 2015 Trends in Biosimilars Report. is the second annual report focused on the introduction of biosimilars in the U.S. market.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: